Literature DB >> 19942154

Drugs that suppress TSH or cause central hypothyroidism.

Bryan R Haugen1.   

Abstract

Many different drugs affect thyroid function. Most of these drugs act at the level of the thyroid in patients with normal thyroid function, or at the level of thyroid hormone absorption or metabolism in patients requiring exogenous levothyroxine. A small subset of medications including glucocorticoids, dopamine agonists, somatostatin analogues and rexinoids affect thyroid function through suppression of TSH in the thyrotrope or hypothalamus. Fortunately, most of these medications do not cause clinically evident central hypothyroidism. A newer class of nuclear hormone receptors agonists, called rexinoids, cause clinically significant central hypothyroidism in most patients and dopamine agonists may exacerbate 'hypothyroidism' in patients with non-thyroidal illness. In this review, we explore mechanisms governing TSH suppression of these drugs and the clinical relevance of these effects.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19942154      PMCID: PMC2784889          DOI: 10.1016/j.beem.2009.08.003

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  46 in total

1.  Evidence for thyrotropin-releasing hormone and glucocorticoid receptor-immunoreactive neurons in various preoptic and hypothalamic nuclei of the male rat.

Authors:  A Cintra; K Fuxe; A C Wikström; T Visser; J A Gustafsson
Journal:  Brain Res       Date:  1990-01-01       Impact factor: 3.252

2.  Effect of one year continuous subcutaneous infusion of a somatostatin analogue, octreotide, on early retinopathy, metabolic control and thyroid function in Type I (insulin-dependent) diabetes mellitus.

Authors:  C Kirkegaard; K Nørgaard; O Snorgaard; T Bek; M Larsen; H Lund-Andersen
Journal:  Acta Endocrinol (Copenh)       Date:  1990-06

3.  The role of glucocorticoids in the regulation of thyrotropin.

Authors:  A Brabant; G Brabant; T Schuermeyer; U Ranft; F W Schmidt; R D Hesch; A von zur Mühlen
Journal:  Acta Endocrinol (Copenh)       Date:  1989-07

4.  Dopamine stimulates release of thyrotrophin-releasing hormone from perfused intact rat hypothalamus via hypothalamic D2-receptors.

Authors:  B M Lewis; C Dieguez; M D Lewis; M F Scanlon
Journal:  J Endocrinol       Date:  1987-12       Impact factor: 4.286

Review 5.  Neuroendocrine control of thyrotropin secretion.

Authors:  J E Morley
Journal:  Endocr Rev       Date:  1981       Impact factor: 19.871

6.  Studies on the conditions determining the inhibitory effect of somatostatin on adrenocorticotropin, prolactin and thyrotropin release by cultured rat pituitary cells.

Authors:  S W Lamberts; J Zuyderwijk; F den Holder; P van Koetsveld; L Hofland
Journal:  Neuroendocrinology       Date:  1989-07       Impact factor: 4.914

7.  Pulsatile thyrotropin release and thyroid function in acromegalics before and during subcutaneous octreotide infusion.

Authors:  F Roelfsema; M Frölich
Journal:  J Clin Endocrinol Metab       Date:  1991-01       Impact factor: 5.958

8.  Effects of dopamine and somatostatin on pulsatile pituitary glycoprotein secretion.

Authors:  M H Samuels; P Henry; E C Ridgway
Journal:  J Clin Endocrinol Metab       Date:  1992-01       Impact factor: 5.958

9.  Effects of carbamazepine on pituitary responsiveness to luteinizing hormone-releasing hormone, thyrotropin-releasing hormone, and metoclopramide in epileptic patients.

Authors:  J I Isojärvi; V V Myllylä; A J Pakarinen
Journal:  Epilepsia       Date:  1989 Jan-Feb       Impact factor: 5.864

10.  Bromocriptine treatment of prolactin secreting macroadenomas: a radiological, ophthalmological and endocrinological study.

Authors:  J W van 't Verlaat; R J Croughs; M J Hendriks; N J Bosma; J W Nortier; J H Thijssen
Journal:  Acta Endocrinol (Copenh)       Date:  1986-08
View more
  63 in total

1.  Postprandial changes of amino acid and acylcarnitine concentrations in dried blood samples.

Authors:  Ralph Fingerhut; Gabriel De Jesus Silva Arevalo; Matthias R Baumgartner; Johannes Häberle; Marianne Rohrbach; Andrés Weinfeld Ávalos Figueroa; Elena María Dardón Fresse; Olga Leticia Polanco; Toni Torresani
Journal:  J Inherit Metab Dis       Date:  2010-07-21       Impact factor: 4.982

2.  Cocaine decreases expression of neurogranin via alterations in thyroid receptor/retinoid X receptor signaling.

Authors:  Jane Kovalevich; Gladys Corley; William Yen; Jae Kim; Scott M Rawls; Dianne Langford
Journal:  J Neurochem       Date:  2012-03-13       Impact factor: 5.372

Review 3.  Thyrotropin isoforms: implications for thyrotropin analysis and clinical practice.

Authors:  Joshua M Estrada; Danielle Soldin; Timothy M Buckey; Kenneth D Burman; Offie P Soldin
Journal:  Thyroid       Date:  2013-12-13       Impact factor: 6.568

4.  Reversible pituitary insufficiency due to bexarotene therapy in a patient with mycosis fungoides.

Authors:  Hulusi Atmaca; Ismail Islek; Nilgün Sentürk
Journal:  Pituitary       Date:  2014-10       Impact factor: 4.107

5.  Drug interactions with levothyroxine therapy in patients with hypothyroidism: observational study in general practice.

Authors:  Gianluca Trifirò; Fabrizio Parrino; Janet Sultana; Francesco Giorgianni; Carmen Ferrajolo; Elisa Bianchini; Gerardo Medea; Salvatore Benvenga; Iacopo Cricelli; Claudio Cricelli; Francesco Lapi
Journal:  Clin Drug Investig       Date:  2015-03       Impact factor: 2.859

Review 6.  Thyroid dysfunction from antineoplastic agents.

Authors:  Ole-Petter Riksfjord Hamnvik; P Reed Larsen; Ellen Marqusee
Journal:  J Natl Cancer Inst       Date:  2011-10-18       Impact factor: 13.506

7.  Thyroid hormone regulation by stress and behavioral differences in adult male rats.

Authors:  Dana L Helmreich; Daniel Tylee
Journal:  Horm Behav       Date:  2011-06-12       Impact factor: 3.587

8.  Central hypothyroidism in adults: better understanding for better care.

Authors:  Solange Grunenwald; Philippe Caron
Journal:  Pituitary       Date:  2015-02       Impact factor: 4.107

9.  Subclinical non-autoimmune hypothyroidism in children with steroid resistant nephrotic syndrome.

Authors:  Kanika Kapoor; Abhijeet Saha; N K Dubey; Parul Goyal; C P Suresh; Vinita Batra; Ashish Dutt Upadhayay
Journal:  Clin Exp Nephrol       Date:  2013-04-13       Impact factor: 2.801

10.  Drug interactions in users of tablet vs. oral liquid levothyroxine formulations: a real-world evidence study in primary care.

Authors:  Valeria Guglielmi; Alfonso Bellia; Elisa Bianchini; Gerardo Medea; Iacopo Cricelli; Paolo Sbraccia; Davide Lauro; Claudio Cricelli; Francesco Lapi
Journal:  Endocrine       Date:  2017-09-14       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.